ALEMBIC PHARMACEUTICALS LTD. - Press Release / Media Release

This is to inform the exchange that our Associate Company, Rhizen Pharmaceuticals SA has released a Press Release announcing that the USFDA has granted Fast Track Designation for RP6530 (tenalisib). <BR> Please find enclosed herewith Rhizen's press release.<BR> <BR> We request you to kindly take the same on record.<BR>